Telomerase as a Prognostic Marker and Therapeutic Target in Paediatric EpendymomaMark Barszczyk(Sunnybrook Health Science Centre)TSpace (University of Toronto)November 21, 2013Cited by 1SaveCiteExport RISWatch citationsRelated PapersGenomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations|Nature Genetics|2014|654Epigenomic alterations define lethal CIMP-positive ependymomas of infancy|Nature|2014|621Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells|Acta Neuropathologica|2014|37